"Designing Growth Strategies is in our DNA"

Huntington’s Disease Treatment Market Size, Share & Industry Analysis, By Drug (Tetrabenazine, Deutetrabenazine, Valbenazine, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2026-2034

Last Updated: December 22, 2025 | Format: PDF | Report ID: FBI107140

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Huntington’s Diseases, Key  Countries/ Regions, 2025
    2. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
    3. Pipeline Analysis, Key Players
    4. Economic Cost Burden for the Treatment of Huntington’s Disease, By Regions
    5. Regulatory & Reimbursement Scenario, By Key Regions
    6. Impact of COVID-19 on the Global Huntington’s Disease Treatment Market
  5. Global Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. H. Lundbeck A/S
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Bausch Health Companies Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Neurocrine Biosciences, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Prilenia Therapeutics
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Novartis AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Lupin
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Hikma Pharmaceuticals PLC
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Dr. Reddy’s Laboratories Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Sun Pharmaceutical Industries, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Huntington’s Diseases, Key  Countries/ Regions, 2025
    2. Key Industry Developments (Mergers, Acquisitions, New Product Launches, etc.)
    3. Pipeline Analysis, Key Players
    4. Economic Cost Burden for the Treatment of Huntington’s Disease, By Regions
    5. Regulatory & Reimbursement Scenario, By Key Regions
    6. Impact of COVID-19 on the Global Huntington’s Disease Treatment Market
  5. Global Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. North America Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Japan
      2. China
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Huntington’s Disease Treatment Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Drug
      1. Tetrabenazine
      2. Deutetrabenazine
      3. Valbenazine
      4. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. H. Lundbeck A/S
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Bausch Health Companies Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Neurocrine Biosciences, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Prilenia Therapeutics
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Novartis AG
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Lupin
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Hikma Pharmaceuticals PLC
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Dr. Reddy’s Laboratories Ltd.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Sun Pharmaceutical Industries, Inc.
        1. Overview
        2. Products & services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Huntington’s Disease Treatment Market Value Share (%), By Drug, 2025 & 2034

Figure 2: Global Huntington’s Disease Treatment Market Value Share (%), By Distribution Channel, 2025 & 2034

Figure 3: Global Huntington’s Disease Treatment Market Value (USD billion), By Region, 2025 & 2034

Figure 4: North America Huntington’s Disease Treatment Market Value (USD billion), by Drug, 2025 & 2034

Figure 5: North America Huntington’s Disease Treatment Market Value Share (%), by Drug, 2025

Figure 6: North America Huntington’s Disease Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 7: North America Huntington’s Disease Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 8: North America Huntington’s Disease Treatment Market Value (USD billion), by Country, 2025 & 2034

Figure 9: North America Huntington’s Disease Treatment Market Value Share (%), by Country, 2025

Figure 10: Europe Huntington’s Disease Treatment Market Value (USD billion), by Drug, 2025 & 2034

Figure 11: Europe Huntington’s Disease Treatment Market Value Share (%), by Drug, 2025

Figure 12: Europe Huntington’s Disease Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 13: Europe Huntington’s Disease Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 14: Europe Huntington’s Disease Treatment Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 15: Europe Huntington’s Disease Treatment Market Value Share (%), by Country/ Sub-Region, 2025

Figure 16: Asia Pacific Huntington’s Disease Treatment Market Value (USD billion), by Drug, 2025 & 2034

Figure 17: Asia Pacific Huntington’s Disease Treatment Market Value Share (%), by Drug, 2025

Figure 18: Asia Pacific Huntington’s Disease Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 19: Asia Pacific Huntington’s Disease Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 20: Asia Pacific Huntington’s Disease Treatment Market Value (USD billion), by Country/ Sub-Region, 2025 & 2034

Figure 21: Asia Pacific Huntington’s Disease Treatment Market Value Share (%), by Country/ Sub-Region, 2025

Figure 22: Rest of the World Huntington’s Disease Treatment Market Value (USD billion), by Drug, 2025 & 2034

Figure 23: Rest of the World Huntington’s Disease Treatment Market Value Share (%), by Drug, 2025

Figure 24: Rest of the World Huntington’s Disease Treatment Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 25: Rest of the World Huntington’s Disease Treatment Market Value Share (%), by Distribution Channel, 2025

Figure 26: Global Huntington’s Disease Treatment Market Share Analysis (%), By Company, 2025

Table 1: Global Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 2: Global Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 3: Global Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Region, 2021-2034

Table 4: North America Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 5: North America Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 6: North America Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Country, 2021-2034

Table 7: Europe Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 8: Europe Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 9: Europe Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 10: Asia Pacific Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 11: Asia Pacific Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Table 12: Asia Pacific Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2021-2034

Table 13: Rest of the World Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Drug, 2021-2034

Table 14: Rest of the World Huntington’s Disease Treatment Market Revenue (USD billion) Forecast, By Distribution Channel, 2021-2034

Huntington's Disease Treatment Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 133
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports